Umckaloabo Patents Challenged

Highlighting the legal minefield of bioprospecting, Germany's Schwabe Pharmaceuticals is facing a challenge to two European Patent Office (EPO) patents for its phytopharmaceutical Umckaloabo, which is extracted from the root of South Africa's Pelargonium sidoides plant. Swiss non-governmental organisation (NGO) Berne Declaration and the African Centre for Biosafety (ACB) are assisting a local community in South Africa to challenge patents relating to

To read the full article, please choose one of the following options: